Search

everythinglearnresearchcommunity

for

Search:↓

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

CT60 polymorphism might increase the risk of Alopecia Areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Possible link between androgens and COVID-19 severity; more research needed.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Genetic discoveries are leading to new treatments for alopecia areata.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Researchers made a mouse model with curly hair and hair loss by editing a gene.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.